AMR Logo.png
Patient Monitoring Devices Market Size to Grow $44.86 Billion by 2027 at 4.4% CAGR
09 nov. 2020 10h00 HE | Allied Market Research
Portland, OR, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Patient Monitoring Devices Market by Product (Hemodynamic, Neuromonitoring, Cardiac, Fetal &...
Biotricity.jpg
Biotricity Provides Quarter Update and Announces Continued Growth
01 sept. 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its...
22157.jpg
Global Mobile Cardiac Telemetry Systems Market by Application, End-user and Region - Forecast to 2026
26 août 2020 06h23 HE | Research and Markets
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Global Mobile Cardiac Telemetry Systems Market By Application (Lead based and Patch Based), By End User (Hospitals, Cardiac centers and Other...
Biotricity.jpg
Biotricity Receives FDA clearance for Bioflux Software II System
04 août 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k)...
Biotricity.jpg
Biotricity’s Real-Time Monitoring Bioflux Device can Help Identify Life Threatening QT Prolongation in COVID-19 Patients
07 avr. 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Bioflux® units are...
FDA Grants ‘Breakthrough’ Designation to Eko’s ECG-based Low Ejection Fraction Screening Algorithm, Designed to Improve Detection of Heart Failure
FDA Grants ‘Breakthrough’ Designation to Eko’s ECG-based Low Ejection Fraction Screening Algorithm, Designed to Improve Detection of Heart Failure
18 déc. 2019 09h00 HE | Eko
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug...
Eko CORE digital stethoscope
Eko Makes Stethoscopes Even Smarter with the Redesigned CORE
25 nov. 2019 13h00 HE | Eko
San Francisco, CA, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company with an AI-powered cardiac screening platform, today announced the second generation of its CORE product line. An...
Eko_Logo_Black.png
Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope
18 nov. 2019 07h00 HE | Eko
SAN FRANCISCO , Nov. 18, 2019 (GLOBE NEWSWIRE) -- On November 16 at the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying artificial intelligence (AI) and...
Biotricity.jpg
Biotricity Shows Continued Growth in Core Revenue for Fiscal Q2
07 nov. 2019 08h00 HE | biotricity
REDWOOD CITY, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced financial results for its...
Eko Home
Eko Launches ‘Eko Home,' a Cardiac Remote Monitoring Application Enabling Powerful Drug-Data Combinations to Enhance Clinical Studies and Pharmaceutical Trials
25 juil. 2019 13h00 HE | Eko
San Francisco, July 25, 2019 (GLOBE NEWSWIRE) -- Eko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced Eko Home, a...